Máj- és epeúti rák: vizsgálatok itt: Lengyelország
22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
- Where
- Krakow, Lublin, Olsztyn, Poznan, Słupsk, Tomaszów Mazowiecki
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07284121 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Cracow
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Cracow, Lodz, Rzeszów, Siedlce, Skorzewo
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1/2. fázisTaking peopleA Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- Where
- Gdansk, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 198 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07291076 · EU 2025-523602-33-00 - 3. fázisTaking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Bialystok, Cracow, Katowice, Lublin, Warsaw
- Életkor
- 18 év to 99 év
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - 3. fázisTaking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Bydgoszcz, Cracow, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
- Életkor
- 18 év and over
- People
- 1220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Bydgoszcz, Warsaw
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisTaking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Cracow, Warsaw
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 3. fázisTaking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Cracow, Koszalin, Lodz, Olsztyn, Warsaw
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - 1. fázisTaking peopleA Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
- Where
- Brzozów, Koszalin, Lublin, Olsztyn, Przemyśl
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391670 · EU 2025-521639-34-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Cracow, Gliwice, Warsaw
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 2. fázisTaking peopleStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Cracow, Lublin, Otwock, Warsaw
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - 3. fázisTaking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Warsaw
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00 - 4. fázisTaking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Cracow, Gdansk, Warsaw
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - 4. fázisTaking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Gdansk, Warsaw
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseNot yet taking people in Lengyelország15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial
- Where
- Warsaw
- Életkor
- 18 év and over
- People
- 600
- Run by
- Medical University of Warsaw
See details and how to joinNCT07237204 - 3. fázisTaking peopleA clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
- Where
- Białystok, Bydgoszcz, Gdansk, Katowice, Krakow, Łódź, Lublin, Poznań, Rzeszów, Szczecin, Warsaw, Wrocław, Zabrze
- Életkor
- Up to 64 év
- People
- 60
- Run by
- Medical University Of Gdansk
See details and how to join2024-514635-26-00 · EU 2024-514635-26-00 - No phaseTaking peoplectDNA Monitoring in Patients With HCC and mCRC
- Where
- Warsaw
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- Medical University of Warsaw
See details and how to joinNCT07001085 - 2. fázisNot yet taking people in LengyelországA Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
- Where
- Koszalin, Warsaw
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Akeso
See details and how to joinNCT06984718 · EU 2025-524591-30-00 - 3. fázisTaking peopleNamodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Where
- Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 471 worldwide
- Run by
- Can-Fite BioPharma
See details and how to joinNCT05201404 - No phaseTaking peopleTANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
- Where
- Warsaw
- Életkor
- 18 év to 80 év
- People
- 154
- Run by
- Medical University of Warsaw
See details and how to joinNCT06050200